Author: Rosalind Hill

Mirvaso® approved by European Commission

Galderma has announced that the European Commission has granted Marketing Authorisation in Europe for Mirvaso® (brimonidine) 3 mg/g gel. Mirvaso is an alpha-2 adrenergic receptor agonist that acts rapidly and can...

Read More

Tissue in a syringe: the new kid on the block

At this year’s IMCAS Paris congress, collagen was firmly back on the agenda as start-up company EternoGen LLC unveiled its Advanced Collagen Replenishment portfolio, comprising Rapid Polymerizing Collagen (RPC) and...

Read More

Login Status

January/February 2026 Issue

Upcoming Events

No events are found.